Pablo A VialMarcela FerrésVIAL COX, MARIA CECILIAMARIA CECILIAVIAL COXJonas KlingströmClas AhlmLOPEZ HERNANDEZ, RENE RAMONRENE RAMONLOPEZ HERNANDEZNicole Le CorreGregory J Mertz2024-02-062024-02-062023Vial, P. A., Ferrés, M., Vial, C., Klingström, J., Ahlm, C., López, R., Le Corre, N., & Mertz, G. J. (2023). Hantavirus in humans: A review of clinical aspects and management. The Lancet Infectious Diseases, 23(9), e371-e382. https://doi.org/10.1016/S1473-3099(23)00128-7https://repositorio.udd.cl/handle/11447/7570https://investigadores.udd.cl/handle/123456789/841610.1016/S1473-3099(23)00128-72-s2.0-85162136592WOS:001072260600001communicable diseasesendothelial cellshantavirus infectionshantavirus pulmonary syndromehemorrhagic fever with renal syndromehumansorthohantavirusantivirus agentfavipiraviricatibantinactivated virus vaccineneutralizing antibodyribavirinandes virusasiacase fatality rateclinical featureclinical outcomedifferential diagnosisendemic diseaseeuropeextracorporeal oxygenationhantavirus pulmonary syndromehemorrhagic fever with renal syndromehost pathogen interactionhumaninfectious pregnancy complicationsintensive care unitnewbornnonhumanorgan systemspediatric patientpost exposure prophylaxispregnancy outcomereal time polymerase chain reactionreviewrodentseoul virusserologysupportive care needtreatment indicationvirus cell interactionvirus diagnosiswestern hemispherecommunicable diseaseendothelium cellhantavirushantavirus infectionhantavirus pulmonary syndromehemorrhagic fever with renal syndromepathologyResource Types::text::journal::journal article